AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Northera - API Insight, 2019-2021 - ResearchAndMarkets.com

April 5, 2019

DUBLIN--(BUSINESS WIRE)--Apr 5, 2019--The “Northera - API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Northera - API Insight, 2019 provides product and API manufacturers’ details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Northera. The report also highlights the patent details of Northera.

Scope of the Report

  • A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
  • Patent information around Northera in United States (US) and Europe (EU) has been highlighted
  • API manufacturers for Northera in United States, Europe, China and India
  • The report contains historical and forecasted sales for Northera till 2021
  • Enlists the market competition and emerging therapies in the space where Northera operates

Reasons to Buy

  • Evaluate the marketing status of Northera to exploit opportunities for generic Northera development opportunities
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Northera
  • API intelligence over Northera and gaining primary intelligence over Active Ingredient manufacturers by country
  • Make more informed business decisions from insightful and in-depth analysis of the Northera’s performance

Key Topics Covered

1. Northera Overview

2. Northera Global Sales Assessment

  • Northera Historical Global Sales
  • Northera Forecasted Global Sales

3. Product Description

  • Mechanism of Action
  • Pharmacodynamic Properties
  • Pharmacokinetic Properties

4. Product Details by country

5. Patent Information

6. Global API Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/7f9xai

View source version on businesswire.com:https://www.businesswire.com/news/home/20190405005420/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 04/05/2019 02:26 PM/DISC: 04/05/2019 02:26 PM

http://www.businesswire.com/news/home/20190405005420/en